- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Generic Pharmaceuticals
K-V Pharmaceutical Co
+ Add to WatchlistKVPHQ:US
0.1369 USD 0.0069 5.31%As of 17:20:00 ET on 06/18/2013.
Snapshot for K-V Pharmaceutical Co (KVPHQ)
| Open: | 0.1250 | Day's Range: | 0.1250 - 0.1369 | Volume: | 30,266 |
|---|---|---|---|---|---|
| Previous Close: | 0.1300 | 52wk Range: | 0.0260 - 1.2500 | 1-Yr Rtn: | -81.75% |
Key Statistics for KVPHQ
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(03/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -1.2700 |
| Est. EPS (03/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 8.90 |
| Shares Outstanding (M) | 48.81 |
| 30 Day Average Volume | 218,942 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | 0.3542 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | - |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for KVPHQ
No data available
Company Profile & Key Executives for KVPHQ
K-V Pharmaceutical Company researches, develops, manufactures, and markets controlled-release and taste masked forms of drug products using proprietary drug delivery and taste masking technologies. The Company also markets generic pharmaceuticals.
| Gregory J Divis Jr "Greg"President/CEO | Thomas S McHugh "Tom"CFO/Chief Acctg Ofcr/Treasurer |
| Patrick J ChristmasVP/General Counsel | Brad EdwardsInvestor Relations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
KVPHQ News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page